16Feb
15Feb
Independent Research with Myomo’s MyoPro® Shows Clinically Significant Gains in Motor Function in Individuals with Chronic Moderate-to-Severe Arm Weakness
Myomo, Inc., a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, announces that new research measuring the benefits of the Company’s MyoPro myoelectric orthosis found “statistically significant improvements” in a number of motor function measurements. The research study, titled “Myoelectric Arm Orthosis in Motor Learning-Based Therapy for Chronic Deficits After Stroke and Traumatic Brain Injury,” was funded by the U.S. Army Medical Research Acquisition Activity, and supported by the Office of...
14Feb
Six Wines to Drink Now this Valentine’s Day
Wine and chocolate are at the top of many of our “favorites” lists, and for good reason. Not only are they both enjoyable on their own, but together they can create a unique pairing experience. With Valentine’s Day around the corner, we asked our in-house wine experts for six wine recommendations to enjoy this Valentine’s Day. Archer Roose Rosé, Provence, France--Dry and fruit-forward, with notes of strawberry, raspberry, and apricot compote. Our rosé wine is sustainably sourced from the heart...
10Feb
Google Chooses Pixability as its Exclusive YouTube Insights Partner for AdBlitz
Pixability the provider of software and insights for video advertising on YouTube and other leading Connected TV platforms, today announced that Google has again made the company an exclusive partner for insights around AdBlitz. Google has been partnering with Pixability on Super Bowl insights since 2015, and in that time the two companies have worked together to deliver deep data insights to advertisers around AdBlitz trends and consumer patterns. Read more >>
09Feb
Akston Biosciences Announces Publication in Vaccine of Positive Data for a Room Temperature Protein Subunit COVID-19 Vaccine
Akston Biosciences Corporation, a developer of new classes of biologic therapeutics, announced publication of positive results from a 60-subject, open-label, Phase I trial of AKS-452, its shelf stable protein subunit COVID-19 vaccine candidate. The adjuvanted vaccine was generally well-tolerated and produced a 100% seroconversion rate in the 90 µg single-dose regimen, as well as in the 45 µg and 90 µg two-dose regimens -- Protein subunit vaccine, shelf stable for at least 6 months at 25 degrees C (77 degrees...
09Feb
eSight and Be My Eyes Announce Winner of their eSight 4 Sweepstakes
Leading vision-enhancement platform, eSight, and Be My Eyes, a community-based virtual assistance platform, today announce the recipient of their eSight 4 device sweepstakes. College student Shana Newton of Eugene, Oregon, can now go back to class unimpeded by her visual acuity after being selected as a winner in Be My Eyes’ drawing for eSight’s life-changing eyewear. When Be My Eyes contacted Newton about her awarded unit, eSight engaged Shana via the eSight TeleHealth Program to coach her on the use...
09Feb
WiLS Partners with Scrible to Help Wisconsin Schools Affordably Access its Research and Writing Super App
Scrible, the super app that streamlines the research and writing process for students and educators, announced today its partnership with WiLS (formerly Wisconsin Library Services) to provide its members access to Scrible at a substantial discount. WiLS is a non-profit membership organization that facilitates collaborative projects and services to advance library service and help its members across the state of Wisconsin save time and money. The organization now offers Scrible's paid plans (Scrible Edu Pro Teacher Plan, School Plan and...
09Feb
Easier-To-Produce Room Temperature Covid Shot Shows Promise In Early Clinical Trials
A protein-based Covid-19 vaccine by Akston Biosciences that can be stored at room temperature and efficiently manufactured using existing technology was well-tolerated and provoked an immune response in all those receiving higher doses, according to data from an early-stage clinical trial, as the company vies to expand vaccine access around the world. The early-stage clinical trial, published in the medical journal Vaccine, tested the shot in 60 healthy adults ages 18 to 65 years in the Netherlands, who received one...
05Feb
In Her Own Words: Covid propels Teresa Whalen to improve cancer treatment
As Omnicron continues to take a toll on the country, we’re reminded how many women are on the front lines of health care. Some in the hospital setting, some as public health leaders and others, like Teresa Whalen, in the research lab where, as CEO of CytoAgents, she leads a team of world-renowned clinical drug development experts and scientific advisory board members to find treatments for Cytokine Release Syndrome (CRS), an overreaction of the immune system causing systemic inflammation. Read...
03Feb